We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Drugmakers are reporting shortages of two drugs needed for ventilator patients as demand increases due to COVID-19, propofol and dexmedetomidine. Read More
The EMA said it will allow firms struggling to meet quality requirements when they increase manufacturing capacity to meet demand during the COVID-19 pandemic to use a risk-based approach. Read More
The World Health Organization (WHO) has reported that there are 70 novel coronavirus vaccines in development around the globe with three already in human trials. Read More
Gilead’s antiviral drug remdesivir showed clinical improvement in two-thirds of COVID-19 patients in a study at Los Angeles’ Cedars-Sinai Hospital. Read More
Eli Lilly’s arthritis treatment Olumiant (baricitinib) is being investigated as a potential COVID-19 treatment in one arm of a National Institutes for Allergy and Infectious Diseases adaptive trial. Read More